科研製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2018/11/26 | 5,540 | 5,600 | 5,540 | 5,580 | -10 | -0.2% | 87,100 |
2018/11/22 | 5,500 | 5,590 | 5,500 | 5,590 | +90 | +1.6% | 55,500 |
2018/11/21 | 5,430 | 5,550 | 5,430 | 5,500 | +10 | +0.2% | 101,900 |
2018/11/20 | 5,540 | 5,620 | 5,490 | 5,490 | +40 | +0.7% | 202,800 |
2018/11/19 | 5,580 | 5,640 | 5,430 | 5,450 | -70 | -1.3% | 199,500 |
2018/11/16 | 5,540 | 5,670 | 5,510 | 5,520 | -10 | -0.2% | 174,900 |
2018/11/15 | 5,600 | 5,610 | 5,500 | 5,530 | -110 | -2% | 84,800 |
2018/11/14 | 5,700 | 5,720 | 5,630 | 5,640 | -40 | -0.7% | 99,000 |
2018/11/13 | 5,680 | 5,720 | 5,650 | 5,680 | -130 | -2.2% | 64,100 |
2018/11/12 | 5,780 | 5,860 | 5,780 | 5,810 | +10 | +0.2% | 42,500 |
2018/11/09 | 5,800 | 5,850 | 5,780 | 5,800 | +20 | +0.3% | 56,800 |
2018/11/08 | 5,850 | 5,850 | 5,770 | 5,780 | +60 | +1% | 68,000 |
2018/11/07 | 5,630 | 5,760 | 5,620 | 5,720 | +20 | +0.4% | 84,400 |
2018/11/06 | 5,670 | 5,800 | 5,670 | 5,700 | +30 | +0.5% | 76,800 |
2018/11/05 | 5,600 | 5,700 | 5,600 | 5,670 | +20 | +0.4% | 70,700 |
2018/11/02 | 5,600 | 5,670 | 5,560 | 5,650 | +100 | +1.8% | 84,400 |
2018/11/01 | 5,560 | 5,650 | 5,530 | 5,550 | -110 | -1.9% | 116,800 |
2018/10/31 | 5,510 | 5,670 | 5,510 | 5,660 | +120 | +2.2% | 94,000 |
2018/10/30 | 5,500 | 5,570 | 5,500 | 5,540 | +20 | +0.4% | 102,300 |
2018/10/29 | 5,660 | 5,710 | 5,510 | 5,520 | -60 | -1.1% | 76,200 |
2018/10/26 | 5,600 | 5,630 | 5,510 | 5,580 | -40 | -0.7% | 97,600 |
2018/10/25 | 5,750 | 5,790 | 5,610 | 5,620 | -230 | -3.9% | 99,200 |
2018/10/24 | 5,880 | 5,900 | 5,810 | 5,850 | +70 | +1.2% | 70,900 |
2018/10/23 | 5,890 | 5,890 | 5,760 | 5,780 | -160 | -2.7% | 84,600 |
2018/10/22 | 5,960 | 5,980 | 5,890 | 5,940 | -30 | -0.5% | 50,300 |
2018/10/19 | 5,900 | 5,980 | 5,890 | 5,970 | +40 | +0.7% | 92,100 |
2018/10/18 | 5,930 | 6,000 | 5,910 | 5,930 | ±0 | ±0% | 72,700 |
2018/10/17 | 5,870 | 5,960 | 5,810 | 5,930 | +160 | +2.8% | 83,500 |
2018/10/16 | 5,680 | 5,800 | 5,680 | 5,770 | +50 | +0.9% | 73,800 |
2018/10/15 | 5,760 | 5,840 | 5,690 | 5,720 | -40 | -0.7% | 102,500 |
2018/10/12 | 5,870 | 5,870 | 5,710 | 5,760 | -50 | -0.9% | 145,100 |
2018/10/11 | 5,840 | 5,880 | 5,760 | 5,810 | -130 | -2.2% | 119,300 |
2018/10/10 | 5,900 | 5,970 | 5,870 | 5,940 | +100 | +1.7% | 101,600 |
2018/10/09 | 5,930 | 5,990 | 5,820 | 5,840 | -110 | -1.8% | 102,000 |
2018/10/05 | 5,930 | 6,010 | 5,910 | 5,950 | ±0 | ±0% | 82,500 |
2018/10/04 | 6,040 | 6,050 | 5,940 | 5,950 | -40 | -0.7% | 99,600 |
2018/10/03 | 6,030 | 6,080 | 5,990 | 5,990 | -50 | -0.8% | 72,800 |
2018/10/02 | 5,990 | 6,060 | 5,940 | 6,040 | +50 | +0.8% | 108,700 |
2018/10/01 | 6,020 | 6,070 | 5,920 | 5,990 | -50 | -0.8% | 95,500 |
2018/09/28 | 6,050 | 6,100 | 6,010 | 6,040 | +40 | +0.7% | 65,300 |
2018/09/27 | 6,040 | 6,120 | 5,980 | 6,000 | -70 | -1.2% | 99,900 |
2018/09/26 | 6,020 | 6,070 | 5,960 | 6,070 | -10 | -0.2% | 85,300 |
2018/09/25 | 5,950 | 6,090 | 5,950 | 6,080 | +150 | +2.5% | 128,300 |
2018/09/21 | 5,830 | 5,990 | 5,740 | 5,930 | +140 | +2.4% | 173,700 |
2018/09/20 | 5,850 | 5,870 | 5,770 | 5,790 | -80 | -1.4% | 91,100 |
2018/09/19 | 5,840 | 5,890 | 5,800 | 5,870 | +60 | +1% | 92,300 |
2018/09/18 | 5,680 | 5,830 | 5,670 | 5,810 | +130 | +2.3% | 110,800 |
2018/09/14 | 5,670 | 5,730 | 5,650 | 5,680 | +40 | +0.7% | 117,700 |
2018/09/13 | 5,630 | 5,730 | 5,620 | 5,640 | +40 | +0.7% | 73,800 |
2018/09/12 | 5,570 | 5,650 | 5,540 | 5,600 | -20 | -0.4% | 105,400 |
1601~
1650
件表示中 / 3725件
類似銘柄と比較する
現在ご覧いただいている「科研薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
科研薬 | 384,400円 | -6.4% | -71.8% | 4.94% | 42.94倍 | 0.96倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
ジーエヌアイ | 376,500円 | +21.7% | +999.9% | 0.00% | 15.77倍 | 5.22倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
鳥居薬 | 633,000円 | +7.1% | -35.0% | 0.00% | 52.34倍 | 1.46倍 |
|
JT傘下。皮膚疾患や腎・透析、花粉症薬などアレルゲン領域に強み。塩野義製薬がTOB実施 |
東和薬品 | 295,300円 | +7.9% | -3.3% | 2.71% | 8.21倍 | 0.85倍 |
|
後発医薬品メーカーで国内2強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
ゼリア新薬 | 204,800円 | +3.1% | -6.5% | 2.34% | 9.50倍 | 1.01倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
市場注目の銘柄
チャート関連のコラム